SNYR

Synergy CHC Corp

Add to Watchlist

Advanced Chart

3.360

-0.1(-2.890%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

3.573

Open

3.360

VWAP

3.37

Vol

29.38K

Mkt Cap

30.29M

Low

3.250

Amount

98.89K

EV/EBITDA(TTM)

Total Shares

9.01M

59.12M

EV/OCF(TTM)

P/S(TTM)

Synergy CHC Corp. is a consumer healthcare and beauty company. The Company is the provider of consumer healthcare, beauty, and lifestyle products. The Company’s brand portfolio consists of FOCUSfactor and Flat Tummy. FOCUSfactor is a brain health supplement brand. Flat Tummy is a lifestyle brand that provides a suite of nutritional products to help women achieve their weight management goals. It has six additional, non-core brands are Hand MD is a complete hand-care brand to help maintain clean and healthy hands while reducing the signs of aging; Perfekt Beauty is in beauty line of products for the eyes, lips, brows, cheeks and skin; Sneaky Vaunt is in lingerie brand with a line of women’s shapewear, bralettes and panties; The Queen Pegasus is in eyelash enhancement products for longer, thicker, natural lashes; Neuragen is in fast-acting topical treatments for neuropathic (nerve) pain, and UrgentRx is in line of fast-acting, portable, powdered over-the-counter medications.

1 Analyst Rating

197.62% Upside

Wall Street analysts forecast SNYR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SNYR is 10.00 USD with a low forecast of 10.00 USD and a high forecast of 10.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

0 Hold

0 Sell

Moderate Buy

197.62% Upside

Current: 3.360

Low

10.00

Averages

10.00

High

10.00

197.62% Upside

Current: 3.360

Low

10.00

Averages

10.00

High

10.00

Roth MKM

Sean McGowan

Strong Buy

Initiates

$10

2025-01-21

Reason

Roth MKM

Sean McGowan

Price Target

$10

2025-01-21

Initiates

Strong Buy

Reason

Roth MKM analyst Sean McGowan initiated coverage of Synergy CHC with a Buy rating and $10 price target. In 2023, the company had successfully trialed Focus Factor RTD beverage in Costco-Texas, and more recently, it had a trial run in Costco-Canada with similarly encouraging results, the analyst tells investors in a research note. Roth contends that the combination of growth in Focus Factor Original and the launch this quarter of Focus Factor RTD will produce strong revenue and Adjusted EBITDA growth.

See All Ratings

Valuation Metrics

The current forward P/E ratio for Synergy CHC Corp (SNYR.O) is 0.00, compared to its 5-year average forward P/E of 0.40. For a more detailed relative valuation and DCF analysis to assess Synergy CHC Corp 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

0.40

Current PE

0.00

Overvalued PE

1.79

Undervalued PE

-0.98

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Fair

5Y Average EV/EBITDA

3.91

Current EV/EBITDA

5.29

Overvalued EV/EBITDA

6.90

Undervalued EV/EBITDA

0.92

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair

5Y Average PS

0.39

Current PS

0.66

Overvalued PS

0.69

Undervalued PS

0.08